U.S. High Growth Tech and AI Stocks

AVITA Medical

Market Cap: US$168.4m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Lumentum Holdings

Market Cap: US$5.4b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

Alnylam Pharmaceuticals

Market Cap: US$37.0b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Travere Therapeutics

Market Cap: US$1.9b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Ascendis Pharma

Market Cap: US$9.5b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Alkami Technology

Market Cap: US$3.1b

Provides cloud-based digital banking solutions in the United States.

TG Therapeutics

Market Cap: US$4.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Ardelyx

Market Cap: US$808.7m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Super Micro Computer

Market Cap: US$26.2b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Blueprint Medicines

Market Cap: US$6.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Legend Biotech

Market Cap: US$5.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Palantir Technologies

Market Cap: US$305.7b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Bitdeer Technologies Group

Market Cap: US$2.7b

Operates as a technology company for blockchain and computing.

Roadzen

Market Cap: US$70.7m

Operates as an insurance technology company.

Silence Therapeutics

Market Cap: US$189.4m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Checkpoint Therapeutics

Market Cap: US$347.6m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

UroGen Pharma

Market Cap: US$454.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

MeiraGTx Holdings

Market Cap: US$405.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Achieve Life Sciences

Market Cap: US$94.7m

A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.

Capricor Therapeutics

Market Cap: US$437.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

SideChannel

Market Cap: US$13.6m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

Soleno Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Vanda Pharmaceuticals

Market Cap: US$231.6m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

ARS Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

RenovoRx

Market Cap: US$40.6m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

OS Therapies

Market Cap: US$36.0m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Madrigal Pharmaceuticals

Market Cap: US$6.5b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Tenaya Therapeutics

Market Cap: US$71.1m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TruGolf Holdings

Market Cap: US$10.0m

Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.

Abeona Therapeutics

Market Cap: US$281.0m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Similarweb

Market Cap: US$614.8m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Gorilla Technology Group

Market Cap: US$333.8m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Pagaya Technologies

Market Cap: US$1.1b

A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.

Spotify Technology

Market Cap: US$131.3b

Provides audio streaming subscription services worldwide.